Neovacs
ALNEV | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0004032746 (+4 more)
- LEI:
- 9695001J9GMM5XYK6482
- Country:
- France
- Address:
- 14 RUE DE LA REPUBLIQUE, 92150 SURESNES
- Website:
- https://www.neovacs.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Neovacs is a biotechnology company operating with a dual-activity model focused on proprietary research and development (R&D) and strategic investment. The company's R&D is centered on its Kinoid technology platform, an active immunotherapy approach designed to create therapeutic vaccines for autoimmune diseases, inflammatory conditions, and allergies. This technology aims to regulate the overproduction of cytokines, with lead programs targeting lupus and allergies. In parallel, Neovacs functions as an investment entity, leveraging its experienced team and an external committee to fund high-potential, innovative companies in the biotechnology (BioTech) and medical device (MedTech) sectors. This strategy combines in-house development of its patented therapeutic platform with a diversified portfolio of investments in emerging life sciences.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Neovacs.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-08 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 273.5 KB | |
| 2025-06-03 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 252.7 KB | |
| 2025-06-02 08:00 |
Share Issue/Capital Change
Regroupement des actions Néovacs et suspension de la faculté d'exercice des val…
|
French | 230.9 KB | |
| 2025-05-27 21:00 |
Share Issue/Capital Change
Levée de fonds de 0,5 MEUR
|
French | 231.6 KB | |
| 2025-05-16 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 230.1 KB | |
| 2025-05-06 20:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 213.4 KB | |
| 2025-05-06 08:00 |
Earnings Release
Résultats annuels 2024
|
French | 255.3 KB | |
| 2025-05-05 12:00 |
Share Issue/Capital Change
Levée de fonds de 1,2 MEUR
|
French | 231.2 KB | |
| 2025-04-30 18:00 |
Capital/Financing Update
Levée de fonds de 0,25 MEUR
|
French | 234.1 KB | |
| 2025-04-17 18:30 |
Share Issue/Capital Change
Levée de fonds de 0,25 M EUR
|
French | 248.3 KB | |
| 2025-04-16 08:00 |
Legal Proceedings Report
Néovacs fait le point sur des rumeurs
|
French | 235.6 KB | |
| 2025-04-02 20:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 210.1 KB | |
| 2025-03-28 08:00 |
Regulatory News Service
Néovacs co-organise la 1ère rencontre Française sur les Nanoparticules Lipidiqu…
|
French | 225.9 KB | |
| 2025-03-25 08:00 |
Capital/Financing Update
Signature d'un avenant à la convention de fiducie
|
French | 238.6 KB | |
| 2025-03-17 20:00 |
Share Issue/Capital Change
Levée de fonds de 0,25 MEUR
|
French | 231.5 KB |
Automate Your Workflow. Get a real-time feed of all Neovacs filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Neovacs via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
